Torren Management’s Outset Medical OM Stock Holding History

Torren Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-208	Closed	-$772	–	1300
2025 Q4	$772	Buy	+208	New	+$1.78K	﹤0.01%	1251

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Torren Management's OM Position: Q1 2026 in Review

Torren Management sold out of Outset Medical (OM) in Q1 2026, closing a stake of 208 shares — an estimated $772 sold.

Torren Management first reported a position in OM in Q4 2025 and held it in 1 quarter. The position peaked at $772 in Q4 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

Torren Management reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
Torren Management sold 208 Outset Medical shares in Q1 2026, an estimated $772.
Torren Management first reported a position in Outset Medical in Q4 2025 and held it in 1 quarter.
Torren Management's Outset Medical position peaked at $772 in Q4 2025.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.